Status:
NOT_YET_RECRUITING
HLA Antibodies in Systemic Lupus Erythematosus
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
HLA Antibodies
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunol...
Eligibility Criteria
Inclusion
- Patients Adults
- Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
- Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
- With sera stored in the biobank
Exclusion
- minor Patients
- Opposing the re-use of their personal data for research purposes
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06921239
Start Date
May 1 2025
End Date
May 1 2026
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Amiens
Amiens, France, 80054